Acute Rejection With DSA ‐Negative Severe Microvascular Inflammation in a Kidney Transplant Recipient With an Isolated DPB1*04 ‐Mismatch Successfully Stabilised With Daratumumab
HLA · 2026
DOI: 10.1111/tan.70560 ↗Kurz gefasst
Fallbericht in der Zeitschrift HLA, 2026. Verfasst von Laura Knödl und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, University Hospital Regensburg, Regensburg, Germany. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Graft Rejection, Inflammation, Kidney Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Microvascular inflammation (MVI) in kidney allografts in the absence of detectable donor‐specific anti‐HLA antibodies (DSA) is increasingly recognised as a cause of premature graft failure following kidney transplantation. Potential mechanisms include NK cell alloreactivity mediated by recognition of mismatched HLA class I molecules (missing‐self) via killer‐immunoglobulin‐like receptors. Here, we report the case of an early kidney allograft rejection with severe MVI on biopsy in a patient that was fully HLA‐matched except for a HLA‐DPB1*04 mismatch in the donor. There were no detectable DSA at any time. MVI was successfully reversed and clinically stabilised with a 9‐month course of daratumumab (anti‐CD38 mAb). This case suggests alternative mechanisms of alloreactivity, such as NK cell‐mediated effects, and highlights the existence of MVI in the absence of detectable B cell alloreactivity. Moreover, this case exemplifies the potential of anti‐CD38 treatment in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, University Hospital Regensburg, Regensburg, Germany.
- Department of Nephropathology, Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nuremberg (FAU) and University Hospital, Erlangen, Germany.
- Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
- Department of Internal Medicine 5-Hematology and Oncology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
- Department of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany.
- Chronix Biomedical GmbH, Göttingen, Germany.
ORCID-Profile: Laura Knödl
Zitieren
APA
Knödl, L., Büttner-Herold, M., Götz, M., Luber, M., Spriewald, B., Oellerich, M., Beck, J., Banas, B., & Zecher, D. (2026). Acute Rejection With DSA ‐Negative Severe Microvascular Inflammation in a Kidney Transplant Recipient With an Isolated DPB1*04 ‐Mismatch Successfully Stabilised With Daratumumab. HLA. https://doi.org/10.1111/tan.70560
Vancouver
Knödl L, Büttner-Herold M, Götz M, Luber M, Spriewald B, Oellerich M, et al. Acute Rejection With DSA ‐Negative Severe Microvascular Inflammation in a Kidney Transplant Recipient With an Isolated DPB1*04 ‐Mismatch Successfully Stabilised With Daratumumab. HLA. 2026. doi:10.1111/tan.70560
BibTeX
@article{Kndl2026,
author = {Knödl, Laura and Büttner-Herold, Maike and Götz, Markus and Luber, Markus and Spriewald, Bernd and Oellerich, Michael and Beck, Julia and Banas, Bernhard and Zecher, Daniel},
title = {Acute Rejection With DSA ‐Negative Severe Microvascular Inflammation in a Kidney Transplant Recipient With an Isolated DPB1*04 ‐Mismatch Successfully Stabilised With Daratumumab},
journal = {HLA},
year = {2026},
doi = {10.1111/tan.70560}
}
EUVIMED